COMMD1 and head and neck squamous cell carcinoma: COMMD1 expression was reduced in ovarian cancer (9, 17), neuroblastoma (18), prostate cancer (9, 19), head and neck squamous-cell carcinoma (HNSCC) (20), lung cancer (21), and colitis-associated cancer progression (22).